A short explainer on where Wegovy stands with regulators as a weight loss treatment. Tap through for the details on its approval status.
Recap by typeshit. Full story at www.polskieradio.pl.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Microdosing Ozempic is catching on, but doctors quoted by The Print warn that unsupervised dose changes may bring weight regain and poorer blood sugar control.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Loading…